Status:
UNKNOWN
Assessment of Bmi-1 on Protein and Molecular Levels in Oral Dysplasia and Squamous Cell Carcinoma: A Diagnostic Study
Lead Sponsor:
Cairo University
Conditions:
Oral Squamous Cell Carcinoma
Eligibility:
All Genders
Phase:
NA
Brief Summary
The aim of the current study is to assess the validation of Bmi-1 detection at both protein and molecular levels in oral epithelial dysplasia and oral squamous cell carcinoma as a biomarker for early ...
Detailed Description
Head and neck squamous cell carcinoma (HNSCC) including oral squamous cell carcinoma (OSCC) has been reported as the sixth most common cause of cancer mortality in the world and the fifth most commonl...
Eligibility Criteria
Inclusion
- In vitro studies.
- Samples used are oral dysplasia and squamous cell carcinoma.
- Diagnostic accuracy of Bmi-1 marker on oral dysplasia and SCC.
- English language published articles only.
Exclusion
- In vivo studies.
- Studies using any techniques other than immunohistochemistry or PCR.
- Samples using any carcinoma rather than squamous cell carcinoma.
- Samples using benign tumors.
- Samples using sarcomas.
Key Trial Info
Start Date :
December 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT03345966
Start Date
December 1 2017
End Date
November 1 2019
Last Update
November 17 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asmaa M. Abou Gabal
Cairo, Egypt